Fanfan Riksani - Diagnos Laboratorium Co Sec

All Insiders . Indonesia . 
Stock . Diagnos Laboratorium Utama . Stakeholders . Insider . Fanfan Riksani
DGNS Stock  IDR 210.00  6.00  2.78%   

Insider

Fanfan Riksani is Co Sec of Diagnos Laboratorium Utama
Age 47
Phone62 21 3193 1833
Webhttps://diagnos.co.id

Diagnos Laboratorium Management Efficiency

The company has return on total asset (ROA) of 0.0297 % which means that it generated a profit of $0.0297 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0603 %, meaning that it generated $0.0603 on every $100 dollars invested by stockholders. Diagnos Laboratorium's management efficiency ratios could be used to measure how well Diagnos Laboratorium manages its routine affairs as well as how well it operates its assets and liabilities.
Diagnos Laboratorium Utama has accumulated 10.45 B in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. Diagnos Laboratorium has a current ratio of 7.11, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Diagnos Laboratorium until it has trouble settling it off, either with new capital or with free cash flow. So, Diagnos Laboratorium's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Diagnos Laboratorium sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Diagnos to invest in growth at high rates of return. When we think about Diagnos Laboratorium's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Imas FinneganDigital Mediatama Maxima
48
Sri MMMedikaloka Hermina PT
N/A
MM MHAMedikaloka Hermina PT
79
HasmoroMedikaloka Hermina PT
74
MB BAMedikaloka Hermina PT
N/A
Christian PrawiroItama Ranoraya
34
Alexander RusliMedikaloka Hermina PT
46
Aristo SetiawidjajaMedikaloka Hermina PT
38
Ida ZuraidaProdia Widyahusada Tbk
46
Budiasto KusumaDigital Mediatama Maxima
43
Heru SyarifItama Ranoraya
58
Dodi NurzaniItama Ranoraya
58
Arie WahyudiMedikaloka Hermina PT
N/A
Magdalena VandryProdia Widyahusada Tbk
N/A
Husen SutakariaMedikaloka Hermina PT
75
Paulus GunawanMedikaloka Hermina PT
72
Sri PaulaniProdia Widyahusada Tbk
52
Imroatul WahidahDigital Mediatama Maxima
29
Hendry HermanItama Ranoraya
42
Muyi MMMedikaloka Hermina PT
N/A
Hastiyudo MBAMedikaloka Hermina PT
N/A
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia. Diagnos Laboratorium operates under Diagnostics Research classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 406 people. Diagnos Laboratorium Utama (DGNS) is traded on Jakarta Exchange in Indonesia and employs 568 people.

Management Performance

Return On Equity0.0603
Return On Asset0.0297

Diagnos Laboratorium Leadership Team

Elected by the shareholders, the Diagnos Laboratorium's board of directors comprises two types of representatives: Diagnos Laboratorium inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Diagnos. The board's role is to monitor Diagnos Laboratorium's management team and ensure that shareholders' interests are well served. Diagnos Laboratorium's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Diagnos Laboratorium's outside directors are responsible for providing unbiased perspectives on the board's policies.
Fanfan Riksani, Co Sec
R Ridwan, Head Unit
Dennis Jacobus, Medical Director
Mesha Sini, Pres Director

Diagnos Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Diagnos Laboratorium a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0603
Return On Asset0.0297
Profit Margin0.06 %
Operating Margin0.06 %
Current Valuation967.86 B
Shares Outstanding1.25 B
Shares Owned By Insiders80.00 %
Price To Earning10.49 X
Price To Sales1.60 X
Revenue302.18 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Diagnos Stock

Diagnos Laboratorium financial ratios help investors to determine whether Diagnos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagnos with respect to the benefits of owning Diagnos Laboratorium security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY